Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
MediWound Shares Lower After Pricing Stock Offering - Biotech Movers
By Armie Margaret Lee
Sep 19, 2017 9:28 AM EDT
PRESS RELEASES
Adamas Announces FDA Approval For Second Indication For GOCOVRI® As An Adjunctive Treatment To Levodopa/carbidopa In Parkinson's Disease Patients Experiencing OFF Episodes
By Business Wire
Feb 1, 2021 2:07 PM EST
PRESS RELEASES
Adamas Announces Settlement Of Patent Litigation With Zydus
By Business Wire
Feb 1, 2021 8:01 AM EST
PRESS RELEASES
Adamas Pharmaceuticals Stock - Kehoe Law Firm, P.C. Investigating Breach Of Fiduciary Duty Claims On Behalf Of ADMS Investors - ADMS Shareholders Encouraged To Contact Kehoe Law Firm, P.C.
By PR Newswire
Mar 19, 2020 4:46 PM EDT
PRESS RELEASES
ADAMAS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Adamas Pharmaceuticals, Inc.'s January 24, 2018 Secondary Public Offering To Contact The Firm
By Business Wire
Feb 7, 2020 11:18 AM EST
PRESS RELEASES
ADMS INVESTOR DEADLINE IN 7 DAYS: Bernstein Liebhard LLP Reminds Investors Of The Deadline To File A Lead Plaintiff Motion In A Securities Class Action Against Adamas Pharmaceuticals, Inc.
By Business Wire
Feb 3, 2020 10:11 AM EST
PRESS RELEASES
ADAMAS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Adamas Pharmaceuticals, Inc. (ADMS) To Contact The Firm
By Business Wire
Jan 31, 2020 11:16 AM EST
PRESS RELEASES
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Adamas Pharmaceuticals, Inc. - ADMS
By PR Newswire
Jan 9, 2020 4:00 AM EST
STOCKS
MediWound Shares Lower After Pricing Stock Offering - Biotech Movers
By Armie Margaret Lee
Sep 19, 2017 9:28 AM EDT
HEALTH
Adamas Skyrockets on FDA Approval for Dyskinesia Treatment - Biotech Movers
By Armie Margaret Lee
Aug 25, 2017 2:08 PM EDT
VIDEO
Hurricane Harvey, Now a Category 2, Heads for Oil-Rich Gulf Coast
By Jane King
Aug 25, 2017 7:55 AM EDT
STOCKS
Biotech's are quite active Tuesday. Find Out who's moving and why:
By William McConnell
Apr 25, 2017 9:59 AM EDT
STOCKS
5 stocks insiders love right now
By Roberto Pedone
Sep 14, 2016 1:36 PM EDT
MARKETS
Adamas Pharmaceuticals (ADMS) Is Weak On High Volume Today
By TheStreet Wire
Jul 25, 2016 10:15 AM EDT
STOCKS
16 Biopharma Companies Besides Medivation That Are Attractive Targets
By Sarah Pringle
Jun 29, 2016 1:28 PM EDT
MARKETS
Adamas Pharmaceuticals (ADMS) Weak On High Volume Today
By TheStreet Wire
Jun 22, 2016 10:21 AM EDT
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: Here Are Today's Top 10 Winning Stocks
By Scott Rutt
Apr 18, 2016 8:21 PM EDT
MARKETS
Adamas Pharmaceuticals (ADMS) Flagged As Strong On High Volume
By TheStreet Wire
Apr 1, 2016 10:08 AM EDT
INVESTING
SLTD, WTW, FB, AMZN: Rev Shark's Views
By James "Rev Shark" DePorre
Jan 4, 2016 1:00 AM EST
MARKETS
Adamas Pharmaceuticals (ADMS) Flagged As Strong On High Volume
By TheStreet Wire
Dec 28, 2015 11:03 AM EST
MARKETS
Perilous Reversal Watch: Adamas Pharmaceuticals (ADMS)
By TheStreet Wire
Dec 24, 2015 9:46 AM EST
MARKETS
Adamas Pharmaceuticals (ADMS) Weak On High Volume
By TheStreet Wire
Jun 23, 2015 11:33 AM EDT
MARKETS
Adamas Pharmaceuticals (ADMS) Flagged As Strong On High Volume
By TheStreet Wire
Jun 16, 2015 10:22 AM EDT
INVESTING
5 Big-Volume Stocks to Trade for Big Breakouts
By Roberto Pedone
Oct 2, 2014 9:20 AM EDT
